DCs Vaccine Combined With Cytokine-induced Killer Cells in Patients With AML

NCT01898663 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

High-risk Soft Tissue Sarcoma

Interventions

BIOLOGICAL: Adenovirus-transfected DC + CIK

Sponsor

Affiliated Hospital to Academy of Military Medical Sciences